Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Monday, February 24, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
admin
-
February 3, 2025
Latest Pharma-News
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
admin
-
February 3, 2025
Latest Pharma-News
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
admin
-
January 24, 2025
Latest Pharma-News
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
admin
-
January 24, 2025
Latest Pharma-News
Enzalutamide Approved by FDA for metastatic castration-sensitive prostate cancer (mCSPC) Treatment
admin
-
December 18, 2019
0
Latest Pharma-News
Lynparza recommended by FDA advisory committee for 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer, not Progressed on Platinum-Based Chemotherapy
admin
-
December 18, 2019
0
Latest Pharma-News
Takeda collaborates with MiTest Health to Launch Innovative Disease Risk Prediction Tool to Redefine Crohn’s Disease Management
admin
-
December 18, 2019
0
Latest Pharma-News
Horizon Therapeutics first FDA-approved medicine Teprotumumab for the Treatment of Thyroid Eye Disease (TED)
admin
-
December 17, 2019
0
Latest Pharma-News
U.S. FDA Approved Avadel’s Nouress™ (AV001), a Cysteine Hydrochloride Injection for Treating Neonate Patients Requiring Total Parental Nutrition (TPN)
admin
-
December 17, 2019
0
Latest Pharma-News
FDA approved Salarius’s Seclidemstat by Fast Track Designation for Lead Drug Candidate, in Relapsed or Refractory Ewing Sarcoma
admin
-
December 17, 2019
0
Latest Pharma-News
AstraZeneca completed an Agreement with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia
admin
-
December 17, 2019
0
Latest Pharma-News
Soligenix initiates phase 1C, double-blind, placebo-controlled, phase 1C trial of RiVax, a lyophilized ricin toxin A-chain subunit vaccine with alum-adjuvant
admin
-
December 17, 2019
0
Latest Pharma-News
ViiV Healthcare files submissions to the FDA and EMA for the first-ever dispersible formulation of dolutegravir DTG 50mg film-coated tablet (FCT) in paediatric HIV...
admin
-
December 16, 2019
0
Latest Pharma-News
FDA Approved Amarin’s Vascepa For the cardiovascular problems, Shares Up 5%
admin
-
December 16, 2019
0
Latest Pharma-News
Trastuzumab deruxtecan (DS-8201), accomplished the tumour response rate of 60.9% in pivotal Phase II HER2-positive metastatic breast cancer trial
admin
-
December 13, 2019
0
Latest Pharma-News
First Ever Randomized Phase 3 Clinical Trial (LIBRETTO-431) for the Treatment of Naïve RET Fusion-Positive Non-Small Cell Lung Cancer
admin
-
December 13, 2019
0
1
...
136
137
138
...
145
Page 137 of 145
- Advertisment -
Most Read
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
February 10, 2025
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
February 3, 2025
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
February 3, 2025
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025